NL-OMON31777
Completed
Not Applicable
Clinical Trial to Evaluate the Treatment of Atrial Fibrillation Using the Ablation Frontiers Cardiac Ablation System - The Atrial Fibrillation Ablation Pilot Study
Ablation Frontiers, Inc.0 sites20 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ablation Frontiers, Inc.
- Enrollment
- 20
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •History of symptomatic permanent atrial fibrillation lasting greater than seven days but less than four years with at least one failed DC cardioversion within the previous two years.
Exclusion Criteria
- •Structural heart disease of clinical significance.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
CATALYST TrialJPRN-jRCT2072220013Kozuma Ken120
Completed
Not Applicable
Multicenter study on the effectiveness of atrial fibrillation ablation in secondary prevention of cardiogenic cerebral embolism and systemic embolism.JPRN-UMIN000026074Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences500
Recruiting
Not Applicable
Clinical Effectiveness of Atrial Anti-tachycardia Pacing Therapy in Sick Sinus Syndrome with Previous Atrial Fibrillation Ablation (CEASE-AF)Sick sinus syndromeAtrial FibrillationCardiovascular - Other cardiovascular diseasesACTRN12616001353482Centre for Heart Rhythm Disorders, University of Adelaide, Royal Adelaide Hospital136
Completed
Phase 2
Treatment of cardiac amyloid light-chain amyloidosis with the green tea compound epigallocatechin-3-galiateAmyloid light-chain amyloidosisNutritional, Metabolic, EndocrineAmyloidosisISRCTN68399350Ruprecht-Karls-University of Heidelberg (Germany)38
Completed
Not Applicable
Randomized Evaluation of Atrial Fibrillation treatment with focal impulse and Rotor Modulation guided procedure ( REAFFIRM)Abnormal heartritmepersistent atrial fibrilation10007521NL-OMON43707Abbott Electrophysiology50